Why MakerBot’s Bre Pettis Thinks Driverless Cars Will Stimulate Innovation Within 3D BioPrinting

RAPID

Share this Article

Probably one of the few promising new technologies which can arouse a crowd as easily as 3D printing can, would be driverless cars. We all have heard by now that Google and various car manufacturers are working on technology, which one day very soon, will allow us to sit back and relax as our cars drive us around, totally unassisted.

pet-3There are many benefits to driverless cars. Americans spend an average of 120-150 minutes each day in their vehicles. Imagine what we could be doing with that time, if we didn’t have to pay attention to the road. Some of us may play games or watch the next episode of ‘Breaking Bad’ on Netflix, while others will get a little extra work done so that they can spend more time with their families when they get home. That’s not the main benefit, however. It is estimated that driverless vehicles will cut down on traffic fatalities by as many as 30,000 a year, in the United States alone. That’s 80 deaths avoided each and every day!

MakerBot CEO and cofounder Bre Pettis, yesterday gave a 45 minute open interview at the Northside Festival in Brooklyn. In the interview he discussed all sorts of technologies, mainly 3D printing of course. In the entire 45 minutes, he made one remark which really stuck with many in the audience.

Yes, driverless cars promise to change our lives for the better, as well as save them, but there is one aspect of the life saving attributes of the technology, which may lead to problems, albeit problems we pet-1are happy to be dealt.  If fatalities from motor vehicle accidents all but stop, there will be a huge organ donor supply constraint, as most organs which are donated come from accident victims. If there are no accident victims, we will need to find an alternate supply of healthy organs for transplant patients. I will stop you right here, Pettis did not suggest an organized organ theft ring. What he did suggest is that driverless car technology will spur on massive innovation within the bioprinting space.

pet-feat

There are already several companies around the world working on 3D printing human tissue, with an ultimate goal of bioprinting functioning human organs, like the heart, liver, and kidneys. As the supply curve shifts to the left, the price willing to be paid for such organs will increase substantially. As major biotech firms realize this, they will begin pumping millions, if not billions of dollars into the field of bioprinting.

The world is changing, technology always seems to keep up with the problems we face. Will driverless cars lead to innovation within the bioprinting space? Let us know your opinion in the bioprinting forum thread at 3DPB.com

Share this Article


Recent News

Additive Manufacturing Strategies 2025: Consensus on the Road Ahead for 3D Printing

IperionX Lands $47.1M from DoD for Titanium 3D Printing Powders



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Rapid Fusion Introduces UK’s First Large Format Hybrid 3D Printer for Polymers

Rapid Fusion is set to unveil what it describes as the first UK-built large format hybrid 3D printer, Medusa, at an open day event on February 26 at its Skypark...

ADDiTEC’s AMDROiD X: A Portable DED Metal 3D Printer for Defense

Given the outsized role of the U.S. Department of Defense (DoD) in the additive manufacturing (AM) industry, the Military AM (MILAM) conference in Tampa, Florida, has become a key trade...

UK’s First Homegrown Rocket Launch Nears Reality with £20M Investment

A UK-built rocket launching into space from British soil could finally happen soon. The UK has been working toward this for over a decade. In 2017, the government ramped up...

Featured

Stratasys Secures $120M Investment from Fortissimo Capital Amid Pressure from Bambu Lab

Stratasys Ltd. (NASDAQ: SSYS) has announced a $120 million investment from Fortissimo Capital, an Israeli private equity firm. The deal involves the direct purchase of 11.65 million newly issued shares...